Digital twin for sex-specific identification of class III antiarrhythmic drugs based on in vitro measurements, computer models, and machine learning tools
PLOS Computational Biology · 2025
DOI: 10.1371/journal.pcbi.1013154 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2025. Verfasst von Jieyun Bai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The first Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Anti-Arrhythmia Agents, Machine Learning. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China, High-end Foreign Experts Recruitment Plan of China.
Abstract (Originalsprache)
Atrial fibrillation (AF) significantly affects morbidity and mortality rates. Class III antiarrhythmic drugs (AADs) play a crucial role in managing AF but often exhibit gender-specific complications. Our study aims to identify gender-specific Class III AADs by integrating in vitro measurements, in silico models, and machine learning (ML). By simulating drug effects on a diverse cardiomyocyte model population (5,663 males and 6,184 females), we classified drugs based on changes in action potentials and calcium transients. Using sex-dependent Support Vector Machine (SVM) algorithms, we achieved high prediction accuracy (>89%) and F1 score (>87%). Key features included changes in resting membrane potential and action potential amplitude, duration and area. Gender differences in drug responses were attributed to lower IK1, INa, and Ito in females.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The first Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
- Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
- The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangzhou, China.
- Biological Physics Group, Department of Physics and Astronomy, The University of Manchester, Manchester, United Kingdom.
- Department of Physics and Astronomy, Ghent University, Gent, Belgium.
- World-Class Research Center "Digital biodesign and personalized healthcare", I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
ORCID-Profile: Jieyun Bai, Henggui Zhang, Alexander V Panfilov
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
- High-end Foreign Experts Recruitment Plan of China
- China Scholarship Council
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Bai, J., Wang, W., Zhang, X., Lu, H., Zhang, H., Panfilov, A. V., & Zhao, J. (2025). Digital twin for sex-specific identification of class III antiarrhythmic drugs based on in vitro measurements, computer models, and machine learning tools. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1013154
Vancouver
Bai J, Wang W, Zhang X, Lu H, Zhang H, Panfilov AV, et al. Digital twin for sex-specific identification of class III antiarrhythmic drugs based on in vitro measurements, computer models, and machine learning tools. PLOS Computational Biology. 2025. doi:10.1371/journal.pcbi.1013154
BibTeX
@article{Bai2025,
author = {Bai, Jieyun and Wang, Weishan and Zhang, Xiaoshen and Lu, Hua and Zhang, Henggui and Panfilov, Alexander V and Zhao, Jichao},
title = {Digital twin for sex-specific identification of class III antiarrhythmic drugs based on in vitro measurements, computer models, and machine learning tools},
journal = {PLOS Computational Biology},
year = {2025},
doi = {10.1371/journal.pcbi.1013154}
}
EUVIMED